Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110


Weight, physical activity, diet, and prognosis in breast and gynecologic cancers.

McTiernan A, Irwin M, Vongruenigen V.

J Clin Oncol. 2010 Sep 10;28(26):4074-80. doi: 10.1200/JCO.2010.27.9752. Epub 2010 Jul 19. Review.


Incidence and time course of bleeding after long-term amenorrhea after breast cancer treatment: a prospective study.

Sukumvanich P, Case LD, Van Zee K, Singletary SE, Paskett ED, Petrek JA, Naftalis E, Naughton MJ.

Cancer. 2010 Jul 1;116(13):3102-11. doi: 10.1002/cncr.25106.


Longer therapy, iatrogenic amenorrhea, and survival in early breast cancer.

Swain SM, Jeong JH, Geyer CE Jr, Costantino JP, Pajon ER, Fehrenbacher L, Atkins JN, Polikoff J, Vogel VG, Erban JK, Rastogi P, Livingston RB, Perez EA, Mamounas EP, Land SR, Ganz PA, Wolmark N.

N Engl J Med. 2010 Jun 3;362(22):2053-65. doi: 10.1056/NEJMoa0909638.


Pregnancy after breast cancer. A comprehensive review.

de Bree E, Makrigiannakis A, Askoxylakis J, Melissas J, Tsiftsis DD.

J Surg Oncol. 2010 May 1;101(6):534-42. doi: 10.1002/jso.21514. Review.


Population-based study of contralateral prophylactic mastectomy and survival outcomes of breast cancer patients.

Bedrosian I, Hu CY, Chang GJ.

J Natl Cancer Inst. 2010 Mar 17;102(6):401-9. doi: 10.1093/jnci/djq018. Epub 2010 Feb 25.


Pregnancy after breast cancer: the importance of active counselling and planning.

Rippy EE, Karat IF, Kissin MW.

Breast. 2009 Dec;18(6):345-50. doi: 10.1016/j.breast.2009.08.003. Epub 2009 Nov 5.


LHRH agonists for adjuvant therapy of early breast cancer in premenopausal women.

Goel S, Sharma R, Hamilton A, Beith J.

Cochrane Database Syst Rev. 2009 Oct 7;(4):CD004562. doi: 10.1002/14651858.CD004562.pub4. Review.


The prevalence of germ-line TP53 mutations in women diagnosed with breast cancer before age 30.

Ginsburg OM, Akbari MR, Aziz Z, Young R, Lynch H, Ghadirian P, Robidoux A, Londono J, Vasquez G, Gomes M, Costa MM, Dimitrakakis C, Gutierrez G, Pilarski R, Royer R, Narod SA.

Fam Cancer. 2009;8(4):563-7. doi: 10.1007/s10689-009-9287-z.


Patient and surgeon characteristics associated with increased use of contralateral prophylactic mastectomy in patients with breast cancer.

Arrington AK, Jarosek SL, Virnig BA, Habermann EB, Tuttle TM.

Ann Surg Oncol. 2009 Oct;16(10):2697-704. doi: 10.1245/s10434-009-0641-z. Epub 2009 Aug 4.


Breast cancer before age 40 years.

Anders CK, Johnson R, Litton J, Phillips M, Bleyer A.

Semin Oncol. 2009 Jun;36(3):237-49. doi: 10.1053/j.seminoncol.2009.03.001. Review.


Prognostic effects of 25-hydroxyvitamin D levels in early breast cancer.

Goodwin PJ, Ennis M, Pritchard KI, Koo J, Hood N.

J Clin Oncol. 2009 Aug 10;27(23):3757-63. doi: 10.1200/JCO.2008.20.0725. Epub 2009 May 18.


The challenge of imaging dense breast parenchyma: is magnetic resonance mammography the technique of choice? A comparative study with x-ray mammography and whole-breast ultrasound.

Pediconi F, Catalano C, Roselli A, Dominelli V, Cagioli S, Karatasiou A, Pronio A, Kirchin MA, Passariello R.

Invest Radiol. 2009 Jul;44(7):412-21. doi: 10.1097/RLI.0b013e3181a53654.


Breast cancer diagnosis during pregnancy.

Litton JK, Theriault RL, Gonzalez-Angulo AM.

Womens Health (Lond). 2009 May;5(3):243-9. doi: 10.2217/whe.09.2. Review.


Endocrine therapy plus zoledronic acid in premenopausal breast cancer.

Gnant M, Mlineritsch B, Schippinger W, Luschin-Ebengreuth G, Pöstlberger S, Menzel C, Jakesz R, Seifert M, Hubalek M, Bjelic-Radisic V, Samonigg H, Tausch C, Eidtmann H, Steger G, Kwasny W, Dubsky P, Fridrik M, Fitzal F, Stierer M, Rücklinger E, Greil R; ABCSG-12 Trial Investigators, Marth C.

N Engl J Med. 2009 Feb 12;360(7):679-91. doi: 10.1056/NEJMoa0806285. Erratum in: N Engl J Med. 2009 May 28;360(22):2379.


Beyond Li Fraumeni Syndrome: clinical characteristics of families with p53 germline mutations.

Gonzalez KD, Noltner KA, Buzin CH, Gu D, Wen-Fong CY, Nguyen VQ, Han JH, Lowstuter K, Longmate J, Sommer SS, Weitzel JN.

J Clin Oncol. 2009 Mar 10;27(8):1250-6. doi: 10.1200/JCO.2008.16.6959. Epub 2009 Feb 9.


Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudy.

Gnant M, Mlineritsch B, Luschin-Ebengreuth G, Kainberger F, Kässmann H, Piswanger-Sölkner JC, Seifert M, Ploner F, Menzel C, Dubsky P, Fitzal F, Bjelic-Radisic V, Steger G, Greil R, Marth C, Kubista E, Samonigg H, Wohlmuth P, Mittlböck M, Jakesz R; Austrian Breast and Colorectal Cancer Study Group (ABCSG).

Lancet Oncol. 2008 Sep;9(9):840-9. doi: 10.1016/S1470-2045(08)70204-3. Epub 2008 Aug 19.


Zoledronic acid prevents bone loss in premenopausal women undergoing adjuvant chemotherapy for early-stage breast cancer.

Hershman DL, McMahon DJ, Crew KD, Cremers S, Irani D, Cucchiara G, Brafman L, Shane E.

J Clin Oncol. 2008 Oct 10;26(29):4739-45. doi: 10.1200/JCO.2008.16.4707. Epub 2008 Aug 18.


Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression.

Anders CK, Hsu DS, Broadwater G, Acharya CR, Foekens JA, Zhang Y, Wang Y, Marcom PK, Marks JR, Febbo PG, Nevins JR, Potti A, Blackwell KL.

J Clin Oncol. 2008 Jul 10;26(20):3324-30. doi: 10.1200/JCO.2007.14.2471. Erratum in: J Clin Oncol. 2011 Sep 20;29(27):3721.


Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropins in patients with breast cancer: a prospective controlled study.

Azim AA, Costantini-Ferrando M, Oktay K.

J Clin Oncol. 2008 Jun 1;26(16):2630-5. doi: 10.1200/JCO.2007.14.8700.


Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study.

Kauff ND, Domchek SM, Friebel TM, Robson ME, Lee J, Garber JE, Isaacs C, Evans DG, Lynch H, Eeles RA, Neuhausen SL, Daly MB, Matloff E, Blum JL, Sabbatini P, Barakat RR, Hudis C, Norton L, Offit K, Rebbeck TR.

J Clin Oncol. 2008 Mar 10;26(8):1331-7. doi: 10.1200/JCO.2007.13.9626. Epub 2008 Feb 11.

Supplemental Content

Support Center